MTX-531

N/A

Report date: 2026/05/09 20:00:18
NME

Base Information

Drug NameMTX-531
Drug Alias Namedual EGFR/PI3K dual inhibitor (MEKanistic Therapeutics)MTX-531
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPI3-kinase class I inhibitorsEpidermal growth factor receptor erbB1 inhibitors
TargetsPI3-kinase class IEpidermal growth factor receptor erbB1
Therapy Area/IndicationsHead and Neck NeoplasmsPancreatic NeoplasmsColorectal Neoplasms +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesMekanistic Therapeutics LLC
China Registration ClassN/A

Develop Information

Active CompaniesMekanistic Therapeutics LLC
Inactive CompaniesN/A
Active IndicationsHead and Neck NeoplasmsPancreatic NeoplasmsColorectal Neoplasms +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A